top of page
ר�קע ירוק למרכיבים.jpg

CINNAMOMUM AROMATICUM

​​Cinnamomum aromaticum has been shown to support blood glucose regulation by enhancing insulin receptor activity and improving cellular glucose uptake.
Its active compounds, including cinnamaldehyde and polyphenols, may mimic insulin function and reduce insulin resistance in individuals with type 2 diabetes.
Cinnamomum aromaticum also exhibits antioxidant and anti-inflammatory properties, contributing to the protection of pancreatic β-cells and the reduction of oxidative stress.
Clinical studies have reported improvements in fasting blood glucose, HbA1c levels, and lipid profiles with regular supplementation.

References:

Hoehn AN, Stockert AL. The Effects of Cinnamomum Cassia on Blood Glucose Values are Greater than those of Dietary Changes Alone. Nutr Metab Insights. 2012 Dec 13;5:77-83.
Costello RB, Dwyer JT, Saldanha L, Bailey RL, Merkel J, Wambogo E. Do Cinnamon Supplements Have a Role in Glycemic Control in Type 2 Diabetes? A Narrative Review. J Acad Nutr Diet. 2016 Nov;116(11):1794-1802.
Mandal A, Sharma S, Rani R, Ranjan S, Kant R, Mirza A. Impact of Cassia Bark Consumption on Glucose and Lipid Control in Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis. Cureus. 2021 Jul 13;13(7):e16376. 
Romeo GR, Lee J, Mulla CM, Noh Y, Holden C, Lee BC. Influence of Cinnamon on Glycemic Control in Individuals With Prediabetes: A Randomized Controlled Trial. J Endocr Soc. 2020 Jul 13;4(11):bvaa094.
Zhu R, Liu H, Liu C, Wang L, Ma R, Chen B, Li L, Niu J, Fu M, Zhang D, Gao S. Cinnamaldehyde in diabetes: A review of pharmacology, pharmacokinetics and safety. Pharmacol Res. 2017 Aug;122:78-89.

front-view-cinnamon-sticks-cinnamon-powders-pinecone-wood-board-dark.jpg

Contact Us

logo leaf.jpg

Have a question or feedback? Feel free to reach out to us, and we'll get back to you as soon as possible.

 

© 2025 by A.M. Powered and secured by Wix 

 

* The results presented are derived from a 22-week prospective pilot study designed to clinically evaluate the effects of a combination of active food supplements (originally tested under
the name "Sugar Crush", currently marketed in the United States under a private label). The trial was conducted in a controlled research setting and is specific to the tested formulation and

conditions described in the study protocol. These findings should not be interpreted as generalizable to all populations or product variations. Real-world results may vary. The data should be

viewed in the context of the clinical trial design, population, and methodology.

bottom of page